Halozyme Therapeutics (HALO) - Stock price history

Stock price history of Halozyme Therapeutics from 2004 to 2025

Annual Stock Price Performance

Year	Performance
2025	42.49%
2024	27.87%
2023	-32.96%
2022	38.58%
2021	-5.19%
2020	135.97%
2019	19.80%
2018	-27.57%
2017	102.80%
2016	-40.62%
2015	76.48%
2014	-35.71%
2013	120.77%
2012	-29.66%
2011	20.38%
2010	29.62%
2009	0.34%
2008	-17.40%
2007	-12.22%
2006	328.19%
2005	-12.08%
2004	-48.24%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
MannKind Corp MNKD	HK$46.11	0.00%	🇺🇸 USA
Eli Lilly LLY	HK$8,374	0.50%	🇺🇸 USA
Baxter BAX	HK$148.59	0.95%	🇺🇸 USA
Pfizer PFE	HK$194.63	0.60%	🇺🇸 USA
Sanofi SNY	HK$376.03	0.08%	🇫🇷 France
Johnson & Johnson JNJ	HK$1,616	0.97%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Stock price history for Halozyme Therapeutics (HALO)